HAVCR2 and neoplasm: There appears to be a decrease in TIM-3 expression on the surface of tumour-infiltrating CD4+ T cells post-FLOT chemotherapy (p = 0.06) and post-CROSS chemoradiotherapy compared with the treatment-naïve setting (p = 0.07) (Fig. 1E.).